UBS AM’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.09M Buy
532,675
+71,499
+16% +$489K ﹤0.01% 1668
2025
Q4
$913K Buy
461,176
+38,345
+9% +$86.9K ﹤0.01% 2171
2025
Q3
$1.04M Sell
422,831
-358,969
-46% -$924K ﹤0.01% 1992
2025
Q2
$2.06M Buy
781,800
+349,459
+81% +$940K ﹤0.01% 2123
2025
Q1
$1.3M Buy
432,341
+170,607
+65% +$517K ﹤0.01% 2196
2024
Q4
$670K Sell
261,734
-1,283,068
-83% -$5.35M ﹤0.01% 2500
2024
Q3
$5.75M Sell
1,544,802
-33,025
-2% -$153K ﹤0.01% 1490
2024
Q2
$9.97M Buy
1,577,827
+1,394,897
+763% +$9.2M ﹤0.01% 1140
2024
Q1
$982K Hold
182,930
﹤0.01% 2025
2023
Q4
$918K Hold
182,930
﹤0.01% 2072
2023
Q3
$309K Hold
182,930
﹤0.01% 2425
2023
Q2
$333K Hold
182,930
﹤0.01% 2444
2023
Q1
$333K Buy
182,930
+35,732
+24% +$111K ﹤0.01% 2444
2022
Q4
$746K Buy
147,198
+11,843
+9% +$65K ﹤0.01% 2000
2022
Q3
$673K Sell
135,355
-18,682
-12% -$85.1K ﹤0.01% 2193
2022
Q2
$573K Buy
154,037
+53,176
+53% +$214K ﹤0.01% 2255
2022
Q1
$566K Hold
100,861
﹤0.01% 2422
2021
Q4
$613K Buy
100,861
+57,722
+134% +$434K ﹤0.01% 2464
2021
Q3
$420K Buy
43,139
+17,217
+66% +$189K ﹤0.01% 2554
2021
Q2
$370K Buy
25,922
+4,222
+19% +$69.7K ﹤0.01% 2606
2021
Q1
$515K Buy
21,700
+9,500
+78% +$246K ﹤0.01% 2378
2020
Q4
$163K Buy
+12,200
New +$117K ﹤0.01% 2524
2016
Q4
Sell
-17,700
Closed -$138K 2566
2016
Q3
$138K Hold
17,700
﹤0.01% 2530
2016
Q2
$110K Buy
+17,700
New +$137K ﹤0.01% 2572
2015
Q4
Sell
-119,221
Closed -$1.37M 2705
2015
Q3
$1.37M Buy
+119,221
New +$2.6M ﹤0.01% 1595

Other funds holding IBRX